Indicated for: prevention of meningococcal disease
Route of administration: injectable
Substance: group C meningococcal polysaccharide vaccine (vaccine)
ATC: J07AH07 (Antiinfectives for systemic use | Bacterial vaccines | Meningococcal vaccines)
The group C meningococcal polysaccharide vaccine is used to prevent infections caused by Neisseria meningitidis serogroup C, a bacterium that can cause meningitis and septicemia. The vaccine contains purified capsular polysaccharides from serogroup C, which stimulate the immune system to produce specific antibodies against this serogroup.
The vaccine is administered subcutaneously or intramuscularly, usually in a single dose, and is recommended for individuals at increased risk of infection, such as those living in crowded communities or traveling to endemic areas.
Common side effects include pain at the injection site, mild fever, and fatigue. In rare cases, severe allergic reactions may occur.
The group C meningococcal polysaccharide vaccine is an important preventive measure for reducing the incidence of meningococcal diseases caused by serogroup C, helping to protect vulnerable populations and prevent outbreaks.